These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 34415167)
1. Interrogating the Inhibition Mechanisms of Human Aldehyde Oxidase by X-ray Crystallography and NMR Spectroscopy: The Raloxifene Case. Mota C; Diniz A; Coelho C; Santos-Silva T; Esmaeeli M; Leimkühler S; Cabrita EJ; Marcelo F; Romão MJ J Med Chem; 2021 Sep; 64(17):13025-13037. PubMed ID: 34415167 [TBL] [Abstract][Full Text] [Related]
2. Potent inhibition of human liver aldehyde oxidase by raloxifene. Obach RS Drug Metab Dispos; 2004 Jan; 32(1):89-97. PubMed ID: 14709625 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of xanthine oxidase by the aldehyde oxidase inhibitor raloxifene: implications for identifying molybdopterin nitrite reductases. Weidert ER; Schoenborn SO; Cantu-Medellin N; Choughule KV; Jones JP; Kelley EE Nitric Oxide; 2014 Feb; 37():41-5. PubMed ID: 24406683 [TBL] [Abstract][Full Text] [Related]
4. Human aldehyde oxidase (hAOX1): structure determination of the Moco-free form of the natural variant G1269R and biophysical studies of single nucleotide polymorphisms. Mota C; Esmaeeli M; Coelho C; Santos-Silva T; Wolff M; Foti A; Leimkühler S; Romão MJ FEBS Open Bio; 2019 May; 9(5):925-934. PubMed ID: 30985987 [TBL] [Abstract][Full Text] [Related]
5. New insights about the monomer and homodimer structures of the human AOX1. Ferreira P; Cerqueira NMFSA; Coelho C; Fernandes PA; Romão MJ; Ramos MJ Phys Chem Chem Phys; 2019 Jul; 21(25):13545-13554. PubMed ID: 31172995 [TBL] [Abstract][Full Text] [Related]
6. In Vitro and In Silico Analyses of the Inhibition of Human Aldehyde Oxidase by Bazedoxifene, Lasofoxifene, and Structural Analogues. Chen S; Austin-Muttitt K; Zhang LH; Mullins JGL; Lau AJ J Pharmacol Exp Ther; 2019 Oct; 371(1):75-86. PubMed ID: 31289113 [TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 3A4-mediated bioactivation of raloxifene: irreversible enzyme inhibition and thiol adduct formation. Chen Q; Ngui JS; Doss GA; Wang RW; Cai X; DiNinno FP; Blizzard TA; Hammond ML; Stearns RA; Evans DC; Baillie TA; Tang W Chem Res Toxicol; 2002 Jul; 15(7):907-14. PubMed ID: 12119000 [TBL] [Abstract][Full Text] [Related]
8. Structural insights into xenobiotic and inhibitor binding to human aldehyde oxidase. Coelho C; Foti A; Hartmann T; Santos-Silva T; Leimkühler S; Romão MJ Nat Chem Biol; 2015 Oct; 11(10):779-83. PubMed ID: 26322824 [TBL] [Abstract][Full Text] [Related]
9. Variability of Zaleplon 5-Oxidase Activity in Mice and Humans, and Inhibition by Raloxifene. Tanoue C; Sugihara K; Tayama Y; Uramaru N; Watanabe Y; Ohta S; Kitamura S Drug Metab Lett; 2017; 10(4):278-285. PubMed ID: 28029084 [TBL] [Abstract][Full Text] [Related]
10. Human liver aldehyde oxidase: inhibition by 239 drugs. Obach RS; Huynh P; Allen MC; Beedham C J Clin Pharmacol; 2004 Jan; 44(1):7-19. PubMed ID: 14681337 [TBL] [Abstract][Full Text] [Related]
11. Application of 4D-QSAR studies to a series of raloxifene analogs and design of potential selective estrogen receptor modulators. Sodero AC; Romeiro NC; da Cunha EF; de Oliveira Magalhaães U; de Alencastro RB; Rodrigues CR; Cabral LM; Castro HC; Albuquerque MG Molecules; 2012 Jun; 17(6):7415-39. PubMed ID: 22706372 [TBL] [Abstract][Full Text] [Related]